Procalcitonin to predict bacterial coinfection in infants with acute bronchiolitis: A preliminary analysis

Pediatric Emergency Care

Volumn 30, Issue 1, 2014, Pages 11-15

  Laham, James L ^a   Breheny, Patrick J ^b   Gardner, Brian M ^c   Bada, Henrietta ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b Department of Epidemiology   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

antibiotics; bacterial infections; bronchiolitis; infants; procalcitonin

Indexed keywords

ANTIBIOTIC AGENT; PROCALCITONIN;

ANTIBIOTIC THERAPY; AREA UNDER THE CURVE; ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; BRONCHIOLITIS; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; INFANT; INTENSIVE CARE UNIT; LEUKOCYTE COUNT; LOGISTIC REGRESSION ANALYSIS; MALE; MEDICAL RECORD REVIEW; METAPNEUMOVIRUS; MIXED INFECTION; NEWBORN; RETROSPECTIVE STUDY; RHINOVIRUS; SENSITIVITY AND SPECIFICITY; THORAX RADIOGRAPHY;

ACUTE DISEASE; BACTEREMIA; BIOLOGICAL MARKERS; BRONCHIOLITIS; CALCITONIN; COINFECTION; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; GLYCOPROTEINS; HUMANS; INFANT; INTENSIVE CARE UNITS, PEDIATRIC; MALE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTEIN PRECURSORS; RETROSPECTIVE STUDIES; ROC CURVE;

EID: 84892983790     PISSN: 07495161     EISSN: 15351815     Source Type: Journal    
DOI: 10.1097/PEC.0000000000000026     Document Type: Article

References (38)

1. Zorc JJ, Breese Hall C. Bronchiolitis: recent evidence on diagnosis and management. Pediatrics. 2010;125:34-349.
2. Corneli HM, Zorc JJ, Majahan P, et al. A multicenter, randomized, controlled trial of dexamethasone for bronchiolitis. N Engl J Med. 2007;357:33-339.
3. Pelletier AJ, Mansbach JM, Camargo CA. Direct medical costs of bronchiolitis hospitalizations in the United States. Pediatrics. 2006;118: 241-2423.
4. Subcommittee on Diagnosis and Management of Bronchiolitis. Diagnosis and management of bronchiolitis. Pediatrics. 2006;118: 177-1793.
5. Wellver RC. Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection. J Pediatr. 2003;143: S11-S117.
6. Levin DL, Garg A, Hall LJ, et al. A prospective randomized controlled blinded study of three bronchodilators in infants with respiratory syncytial virus bronchiolitis on mechanical ventilation. Pediatr Crit Care Med. 2008;9:59-604.
7. Hishiki H, Ishiwada N, Fukasawa C, et al. Incidence of bacterial coinfection with respiratory syncytial virus bronchopulmonary infection in pediatric inpatients. J Infect Chemother. 2011;17:8-90.
8. Gendrel D, Bohuon C. Procalcitonin as a marker of bacterial infection. Pediatr Infect Dis. 2000;19:67-688.
9. Leroy S, Romanello C, Galetto-Lacour A, et al. Procalcitonin to reduce the unnecessary cystographies in children with a urinary tract infection: a European validation study. J Pediatr. 2007;150:8-95.
10. Berger C, Schwarz S, Schaebitz WR, et al. Serum procalcitonin in cerebral ventriculitis. Crit Care Med. 2002;30:177-1781.
11. Deis JN, Creech CB, Estrada CM, et al. Procalcitonin as a marker of severe bacterial infection in children in the emergency department. Pediatr Emerg Care. 2006;26:5-63.
12. Maniaci V, Dauber A, Weiss S, et al. Procalcitonin in young febrile infants for the detection of serious bacterial infections. Pediatrics. 2008;122:70-710.
13. Becker KL, Snider R, Nylen ES. Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations. Crit Care Med. 2008;36:94-952.
14. Galetto-Lacour A, Zamora SA, Gercaix A. Beside procalcitonin and C-reactive protein tests in children with fever without localizing signs of infection seen in a referral center. Pediatrics. 2003;11:105-1060.
15. McMaster P, Park DY, Shann F, et al. Procalcitonin versus C-reactive protein and immature-to-total neutrophil ration as markers of infection after cardiopulmonary bypass in children. Pediatr Crit Care. 2009;10: 21-221.
16. Gendrel D, Raymond J, Coste J, et al. Comparison of procalcitonin with CRP, interleukin-6 and interferon alpha for differentiation of bacterial versus viral infection. Pediatr Infect Dis J. 1999;18:87-881.
17. Fioretto JR, Martin JG, Kurokawa CS, et al. Comparison between procalcitonin and C-reactive protein for early diagnosis of children with sepsis or septic shock. Inflamm Res. 2010;59:58-586.
18. Lacour AG, Zamora SA, Gervaix A. A score identifying serious bacterial infections in children with fever without source. Pediatr Infect Dis J. 2008;27:65-656.
19. Rey C, Los Arcos M, Concha A, et al. Procalcitonin and C-reactive protein as markers of systemic inflammatory response syndrome severity in critically ill children. Intensive Care Med. 2007;33:47-484.
20. Arkader R, Troster EJ, Lopes MR, et al. Procalcitonin does discriminate between sepsis and systemic inflammatory response syndrome. Arch Dis Child. 2006;91:11-120.
21. Willson DF, Landrigan CP, Horn SD, et al. Complications in infants hospitalized for bronchiolitis or respiratory syncytial virus pneumonia. J Pediatr. 2003;143:S14-S149.
22. Byington CL, Enriquez FR, Hoff C, et al. Serious bacterial infections in febrile infants 1 to 90 days old with and without viral infections. Pediatrics. 2004;113:166-1666.
23. Bilavsky E, Shouval DS, Yarden-Bilavsky H, et al. A prospective study of the risk for serious bacterial infections in hospitalized febrile infants with or without bronchiolitis. Pediatr Infect Dis J. 2008;27:26-270.
24. Liebelt EL, Keqin Q, Harvey K. Diagnostic testing for serious bacterial infections in infants aged 90 days or younger with bronchiolitis. Arch Pediatr Adolesc Med. 1999;53:52-530.
25. Autonow JA, Hansen K, McKinstry C, et al. Sepsis evaluations in hospitalized infants with bronchiolitis. Pediatr Infect Dis J. 1998;17: 23-236.
26. Simon L, Saint-Louis P, Amre DK, et al. Procalcitonin and C-reactive protein as markers of bacterial infection in critically ill children at onset of systemic inflammatory response syndrome. Pediatr Crit Care Med. 2008;9:40-413.
27. Kopterides P, Siempos II, Tsangaris I, et al. Procalcitonin-guided algorithms of antibiotic therapy in the intensive care unit: a systematic review and meta-analysis of randomized controlled trials. Crit Care Med. 2010;38:222-2241.
28. Purcell K, Fergie J. Concurrent serious bacterial infections in 2396 infants and children hospitalized with respiratory syncytial virus lower respiratory tract infections. Arch Pediatr Adolesc Med. 2002;156: 32-324.
29. Titus MO, Wright SW. Prevalence of serious bacterial infections in febrile infants with respiratory syncytial virus. Pediatrics. 2003;112: 28-284.
30. Gendrel D, Bohuon C. Procalcitonin in pediatrics for differentiation of bacterial and viral infections. Intensive Care Med. 2000;26:S17-S181.
31. Han YY, Doughty LA, Kofos D. Procalcitonin is persistently increased among children with poor outcome from bacterial sepsis. Pediatr Crit Care Med. 2003;4:2-25.
32. Mantadakis E, Plessa E, Vouloumanou EK, et al. Serum procalcitonin for prediction of renal parenchymal involvement in children with urinary tract infections: a meta-analysis of prospective clinical studies. J Pediatr. 2009;155:87-881.
33. Vouloumanou EK, Plessa E, Karageorgopoulos DE, et al. Serum procalcitonin as a diagnostic marker for neonatal sepsis: a systematic review and meta-analysis. Intensive Care Med. 2011;37:74-762.
34. Zaffanello M, Brugnara M, Franchini M, et al. Is serum procalcitonin able to predict long-term kidney morbidity from urinary tract infections in children? Clin Chem Lab Med. 2008;46:135-1363.
35. Bressan S, Andreola B, Zucchetta P, et al. Procalcitonin as a predictor of renal scaring in infants and young children. Pediatr Nephrol. 2009;24:119-1204.
36. Casado-Flores J, Blanco-Quiros A, Asensio J, et al. Serum procalcitonin in children with suspected sepsis: a comparison with C-reactive protein and neutrophil count. Pediatr Crit Care Med. 2003;4:19-195.
37. Andreola B, Bressan S, Callegaro S, et al. Procalcitonin and C-reactive protein as diagnostic markers of severe bacterial infections in febrile infants and children in the emergency department. Pediatr Infect Dis J. 2007;26:67-677.
38. Toikka P, Irjala K, Juven T, et al. Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children. Pediatr Infect. 2000;19:59-602.